Newsroom

Newsroom

Galderma To Present Five Abstracts in Support of Novel Aesthetics Solutions and Pipeline at ASDS 2020 Annual Meeting

November 6, 2020

Phase 3 READY program of its proprietary, liquid formulation of an investigational botulinum toxin is fully enrolled.

November 6 2020

Galderma To Present Five Abstracts in Support of Novel Aesthetics Solutions and Pipeline at ASDS 2020 Annual Meeting

Phase 3 READY program of its proprietary, liquid formulation of an investigational botulinum toxin is fully enrolled.

Galderma receives approval for Restylane® Vital™, Restylane® Lyft™, and Restylane® Lidocaine in China

October 29, 2020

First approval for a class III medical device for improved skin appearance in China. 

October 29 2020

Galderma receives approval for Restylane® Vital™, Restylane® Lyft™, and Restylane® Lidocaine in China

First approval for a class III medical device for improved skin appearance in China. 

Galderma demonstrates continued commitment to aesthetic education by offering new series of digital webinars*

October 29, 2020

Business-building webinars to support local Aesthetic practices. Expert injector techniques by GAIN faculty.

October 29 2020

Galderma demonstrates continued commitment to aesthetic education by offering new series of digital webinars*

Business-building webinars to support local Aesthetic practices. Expert injector techniques by GAIN faculty.

Galderma Demonstrates Robust Aesthetic Innovation Pipeline with Initiation of Seven New Clinical Studies

October 29, 2020

Ten Data Releases Will Be Presented at the American Society for Dermatologic Surgery (ASDS) Annual Meeting.

October 29 2020

Galderma Demonstrates Robust Aesthetic Innovation Pipeline with Initiation of Seven New Clinical Studies

Ten Data Releases Will Be Presented at the American Society for Dermatologic Surgery (ASDS) Annual Meeting.

Galderma´s Azzalure and Dysport® celebrate a decade of treatment of the glabellar lines

October 29, 2020

Azzalure (marketed as Dysport outside of the EU) for the treatment of glabellar lines marks 10 year anniversary.

October 29 2020

Galderma´s Azzalure and Dysport® celebrate a decade of treatment of the glabellar lines

Azzalure (marketed as Dysport outside of the EU) for the treatment of glabellar lines marks 10 year anniversary.